COSMO Pharmaceuticals SA (COPN) - Total Liabilities

Latest as of December 2025: CHF123.36 Million CHF ≈ $155.96 Million USD

Based on the latest financial reports, COSMO Pharmaceuticals SA (COPN) has total liabilities worth CHF123.36 Million CHF (≈ $155.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of COSMO Pharmaceuticals SA to track the company's year-over-year net asset growth rate.

COSMO Pharmaceuticals SA - Total Liabilities Trend (2004–2025)

This chart illustrates how COSMO Pharmaceuticals SA's total liabilities have evolved over time, based on quarterly financial data. See COSMO Pharmaceuticals SA free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

COSMO Pharmaceuticals SA Competitors by Total Liabilities

The table below lists competitors of COSMO Pharmaceuticals SA ranked by their total liabilities.

Company	Country	Total Liabilities
WEBTOON Entertainment Inc. Common stock NASDAQ:WBTN	USA	$367.24 Million
Max Stock Ltd TA:MAXO	Israel	ILA1.15 Billion
AVALON TECHNOLOGIES LTD NSE:AVALON	India	Rs5.43 Billion
Hunan Corun New Energy Co Ltd SHG:600478	China	CN¥7.30 Billion
Sichuan Jinlu Group Co Ltd SHE:000510	China	CN¥1.54 Billion
Arcadyan Technology Corp TW:3596	Taiwan	NT$38.22 Billion
Smartgroup Corporation Ltd AU:SIQ	Australia	AU$437.33 Million
Taboola NASDAQ:TBLA	USA	$599.79 Million

Liability Composition Analysis (2004–2025)

This chart breaks down COSMO Pharmaceuticals SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of COSMO Pharmaceuticals SA.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.18	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how COSMO Pharmaceuticals SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for COSMO Pharmaceuticals SA (2004–2025)

The table below shows the annual total liabilities of COSMO Pharmaceuticals SA from 2004 to 2025.

Year	Total Liabilities	Change
2025-12-31	CHF123.36 Million ≈ $155.96 Million	-12.93%
2024-12-31	CHF141.68 Million ≈ $179.12 Million	+13.40%
2023-12-31	CHF124.94 Million ≈ $157.96 Million	-57.76%
2022-12-31	CHF295.80 Million ≈ $373.98 Million	+1.00%
2021-12-31	CHF292.88 Million ≈ $370.28 Million	+49.40%
2020-12-31	CHF196.04 Million ≈ $247.84 Million	+2.41%
2019-12-31	CHF191.43 Million ≈ $242.02 Million	+5.86%
2018-12-31	CHF180.83 Million ≈ $228.62 Million	+549.14%
2017-12-31	CHF27.86 Million ≈ $35.22 Million	-0.21%
2016-12-31	CHF27.92 Million ≈ $35.29 Million	-18.60%
2015-12-31	CHF34.30 Million ≈ $43.36 Million	-53.23%
2014-12-31	CHF73.33 Million ≈ $92.71 Million	+220.94%
2013-12-31	CHF22.85 Million ≈ $28.89 Million	-16.13%
2012-12-31	CHF27.24 Million ≈ $34.44 Million	+86.55%
2011-12-31	CHF14.60 Million ≈ $18.46 Million	-56.35%
2010-12-31	CHF33.46 Million ≈ $42.30 Million	+186.73%
2009-12-31	CHF11.67 Million ≈ $14.75 Million	-19.68%
2008-12-31	CHF14.53 Million ≈ $18.37 Million	+20.26%
2007-12-31	CHF12.08 Million ≈ $15.27 Million	-33.86%
2006-12-31	CHF18.27 Million ≈ $23.09 Million	-33.77%
2005-12-31	CHF27.58 Million ≈ $34.87 Million	+13.30%
2004-12-31	CHF24.34 Million ≈ $30.78 Million	--

About COSMO Pharmaceuticals SA

SW:COPN Switzerland Drug Manufacturers - General

Market Cap

$1.26 Billion

CHF1.00 Billion CHF

Market Cap Rank

#7820 Global

#110 in Switzerland

Share Price

CHF58.40

Change (1 day)

-2.67%

52-Week Range

CHF54.40 - CHF124.80

All Time High

CHF171.24